4//SEC Filing
Havanec Laurie P. 4
Accession 0001127602-24-005073
CIK 0000064803other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 5:14 PM ET
Size
9.7 KB
Accession
0001127602-24-005073
Insider Transaction Report
Form 4
Havanec Laurie P.
EVP and Chief People Officer
Transactions
- Award
Common Stock
2024-02-12+16,817→ 37,203 total
Holdings
- 14,678
Common Stock (Restricted)
- 27,643
Stock Option
Exercise: $74.30From: 2022-04-01Exp: 2031-04-01→ Common Stock (27,643 underlying) - 21,829
Stock Option
Exercise: $101.09From: 2023-04-01Exp: 2032-04-01→ Common Stock (21,829 underlying) - 51,959
Stock Option
Exercise: $74.31From: 2024-04-01Exp: 2033-04-01→ Common Stock (51,959 underlying)
Footnotes (4)
- [F1]Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on April 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 12, 2024.
- [F2]Option became exercisable in four equal installments, commencing 4/1/2022.
- [F3]Option became exercisable in four equal installments, commencing 4/1/2023.
- [F4]Option becomes exercisable in four equal installments, commencing 4/1/2024.
Documents
Issuer
CVS HEALTH Corp
CIK 0000064803
Entity typeother
Related Parties
1- filerCIK 0001807757
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 5:14 PM ET
- Size
- 9.7 KB